Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Anand2003 - Reactions of the Intrinsic Pathway of Blood Coagulation with Platelet Activation

ABSTRACT: Inhomogeneous blood coagulation model. Encoded model contains reactions of the intrinsic pathway with platelet activation. Initial conditions provided. Mostly an extension of Zarnitsina1996.

SUBMITTER: Matthew Roberts

PROVIDER: MODEL1806130003 | BioModels | 2018-06-13

REPOSITORIES: BioModels

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	MODEL1806130003?filename=Anand2003.cps	Other
	MODEL1806130003?filename=Anand2003.xml	Xml

Items per page:

1 - 2 of 2

Similar Datasets

Luan2010 - Blood Coagulation Model (extension of Luan2007)

Project description:Mathematical model of blood coagulation. Extension of Luan2007. New reactions, e.g., the activation of platelet by thrombin through PARs, the release of ADP and TXA2 from activated platelets, platelet activation by ADP and TXA2, the intrinsic pathway reactions, were added to the model.

2018-06-25 | MODEL1806250001 | BioModels

Cazzaniga2014 - Blood Coagulation with Platelet Activation

Project description:Mathematical model of blood coagulation with platelet activation. Model includes factor XII, factor VIIIa fragments, meizothrombin, kallikrein, C1-inhibitor, alpha1-Antitrypsin, alpha2-Antiplasmin, fibrinogen and fibrillin.

2018-07-18 | MODEL1807180003 | BioModels

Platelet Activation and a Platelet Biosignature Associates with Enhanced Cardiovascular Risk in Patients with Controlled Psoriasis.

Project description:The underlying mechanisms of atherosclerosis and strategies identifying high cardiovascular (CV) risk in psoriasis are incompletely understood. Platelet activity is increased in psoriasis and induces vascular dysfunction. We investigated the platelet phenotype and platelet transcriptome as one potential mechanism to explain CV risk in psoriasis. Psoriasis and controls underwent platelet aggregation and activation studies and platelet RNA sequencing to generate a psoriasis platelet transcriptomic score. The relationship between the platelet transcriptomic score and CV risk was assessed by arterial stiffness, coronary calcium, and longitudinally in an independent cohort of high CV-risk individuals undergoing lower extremity arterial revascularization (LER).

2025-09-08 | GSE302674 | GEO

Zarnitsina1996 - Reactions of the Intrinsic Pathway of Blood Coagulation

Project description:Model listing the reactions of the intrinsic pathway as listed in Zarnitsina1996. Publication model is a spatio-termporal mathematical model of blood coagulation. Model used as the example of the numerical intrinsic pathway in Braescu et al. (2011). L. Braescu, M. Leretter, T. George, New direct inhibitors and their computed effect on the dynamics of thrombin formation in blood coagulation, in: T. F. George (Ed.), Computational Studies of New Materials II, World Scientific, 2011, 173–190. doi:10.3389/fphys.2012.00266.

2018-06-14 | MODEL1806140001 | BioModels

Effects of Antiplatelet Drugs on Platelet-Dependent Coagulation Reactions.

Project description:Activated platelets are involved in blood coagulation by exposing phosphatidylserine (PS), which serves as a substrate for assembling coagulation complexes. Platelets accelerate fibrin formation and thrombin generation, two final reactions of the coagulation cascade. We investigated the effects of antiplatelet drugs on platelet impact in these reactions and platelet ability to expose PS. Washed human platelets were incubated with acetylsalicylic acid (ASA), ticagrelor, ASA in combination with ticagrelor, ruciromab (glycoprotein IIb-IIIa antagonist), or prostaglandin E1 (PGE1). Platelets were not activated or activated by collagen and sedimented in multiwell plates, and plasma was added after supernatant removal. Fibrin formation (clotting) was monitored in a recalcification assay by light absorbance and thrombin generation in a fluorogenic test. PS exposure was assessed by annexin V staining using flow cytometry. Ticagrelor (alone and in combination with ASA), ruciromab, and PGE1, but not ASA, prolonged the lag phase and decreased the maximum rate of plasma clotting and decreased the peak and maximum rate of thrombin generation. Inhibition was observed when platelets were not treated with exogenous agonists (activation by endogenous thrombin) and pretreated with collagen. Ticagrelor (alone and in combination with ASA), ruciromab, and PGE1, but not ASA, decreased PS exposure on washed platelets activated by thrombin and by thrombin + collagen. PS exposure on activated platelets in whole blood was lower in patients with acute coronary syndrome receiving ticagrelor + ASA in comparison with donors free of medications. These results indicate that antiplatelet drugs are able to suppress platelet coagulation activity not only in vitro but also after administration to patients.

| S-EPMC10377112 | biostudies-literature

Platelet proteomics reveals mechanism of platelet activation inhibition by AEE

Project description:A platelet proteomic approach to reveal the regulatory network by which AEE inhibits platelet activation, thereby preventing thrombosis.

2024-08-14 | PXD054906 |

Luan2007 - Blood coagulation model combining previous models and platelet activation

Project description:Mathematical model combining previous models (Jones1994, Leipoldt1995, Kuhursky2001, Hockin2002) into one model with platelet activation.

2018-06-05 | MODEL1806050001 | BioModels

Xu2002 - Blood Coagulation Model of Activated Factors with Platelet Activation

Project description:System of ODEs to describe the dynamics of several activated factors of blood coagulation. Publication introduces a platelet activation term for synthesis of Xa and IIa.

2018-06-13 | MODEL1806130001 | BioModels

Platelet microRNA-mRNA Co-Expression Profiles Correlate with Platelet Reactivity

Project description:MicroRNAs (miRNAs) regulate cell physiology by altering protein expression, but the biology of platelet miRNAs is largely unexplored. We tested whether platelet miRNA levels were associated with platelet reactivity by genome-wide profiling using platelet RNA from 19 healthy subjects. We found that human platelets express 284 miRNAs. Unsupervised hierarchical clustering of miRNA profiles resulted in 2 groups of subjects that appeared to cluster by platelet aggregation phenotypes. Seventy-four miRNAs were differentially expressed (DE) between subjects grouped according to platelet aggregation to epinephrine, a subset of which predicted the platelet reactivity response. Using whole genome mRNA expression data on these same subjects, we computationally generated a high-priority list of miRNA-mRNA pairs in which the DE platelet miRNAs had binding sites in 3'UTRs of DE mRNAs, and the levels were negatively correlated. Three miRNA-mRNA pairs (miR-200b:PRKAR2B, miR-495:KLHL5 and miR-107:CLOCK) were selected from this list and all 3 miRNAs knocked down protein expression from the target mRNA. Reduced activation from platelets lacking PRKAR2B supported these findings. In summary, (1) platelet miRNAs are able to repress expression of platelet proteins, (2) miRNA profiles are associated with and may predict platelet reactivity, and (3) bioinformatic approaches can successfully identify functional miRNAs in platelets. Total RNA from the platelets of 19 donors was harvested and labeled with Hy3. Reference RNA (a pool of all samples) was labeled with Hy5. This submission represents the miRNA expression component of the study.

2011-09-26 | E-GEOD-27917 | biostudies-arrayexpress

Young blood-derived platelet factors abate inflammation and rescue recognition in aging.

Project description:We show that platelet factors transfer rejuvenating effects of young plasma to the aging brain. Proteomic analysis of plasma from young and aged mice identified age-related changes in platelets. Systemic exposure of aged animals to the platelet fraction of young plasma decreased hippocampal neuroinflammation at a transcriptional and cellular level and ameliorated cognitive impairments. We identified the platelet-derived chemokine CXCL4/Platelet Factor-4 (PF4) as a pro-youthful circulating factor. Systemic PF4 administration decreased age-related neuroinflammation, restored the aging peripheral immune system to a more youthful state, and improved hippocampal-dependent learning and memory in aged mice.

2023-06-20 | GSE173254 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data